Sleepwalking — Causes, Symptoms, Diagnosis & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Sleepwalking (somnambulism) is a disorder of arousal — a NREM (non-rapid eye movement) parasomnia occurring during deep slow-wave sleep (Stage N3, also called slow-wave sleep or SWS), characterised by complex automatic motor behaviours (ambulation, talking, performing routine activities) with incomplete arousal from deep sleep, in which the person is neither fully asleep nor fully awake. During a sleepwalking episode, the motor cortex and limbic system generate behaviours while the prefrontal cortex — responsible for consciousness, judgment, memory formation, and voluntary control — remains in a deep sleep state. This explains the defining features: complex automatic behaviours without conscious awareness, marked unresponsiveness to the environment, and complete amnesia for the episode upon waking. The electroencephalogram during an episode shows a mixture of high-amplitude delta waves (N3 characteristics) and lower amplitude theta/alpha activity — the neurophysiological signature of an incomplete arousal from SWS. Sleepwalking most commonly occurs in the first third of the sleep period (typically 1-2 hours after sleep onset), when SWS abundance is greatest; later-night NREM episodes are relatively rare because SWS concentrates in the first sleep cycles. Prevalence: 1-15% of children, with peak prevalence at ages 8-12 years and strong familial clustering (60-80% of affected children have a first-degree relative with sleepwalking or another NREM parasomnia such as sleep terrors or confusional arousals). Approximately 1.5-4% of adults have at least occasional sleepwalking. The majority of childhood sleepwalking resolves spontaneously during adolescence as SWS abundance declines with pubertal maturation. Adult-onset sleepwalking (first episode after age 18) is less common and warrants investigation for precipitating factors — sleep apnoea, medications (zolpidem, quetiapine), psychiatric conditions, and, rarely, nocturnal frontal lobe epilepsy.

Genetic predisposition is the most important underlying factor for sleepwalking — the familial aggregation is striking: 60-80% of adults with sleepwalking have at least one affected first-degree relative; having a parent who sleepwalks confers approximately 10x the population risk; having both parents with a history of sleepwalking raises the risk to approximately 60%; twin studies show 65-80% concordance in monozygotic twins; the mode of inheritance appears autosomal dominant with variable penetrance; the DQ1 HLA haplotype has been associated in some studies. Precipitating factors (which increase the probability of a sleepwalking episode in a genetically predisposed individual by deepening SWS or increasing arousal threshold fluctuation): sleep deprivation is the most powerful modifiable precipitant — insufficient prior sleep dramatically increases SWS pressure and rebound on the subsequent night, increasing the probability of SWS arousal episodes; any additional night of sleep deprivation in a sleepwalker typically reliably triggers episodes; fever and intercurrent illness (particularly in children — febrile illness increases SWS depth and instability, explaining the clustering of episodes around viral infections); psychological stress and anxiety (increasing nocturnal arousal oscillations during SWS); alcohol ingestion (suppresses REM in the early sleep period, increasing SWS rebound in the second half of the night — paradoxically increasing NREM parasomnia risk despite its sedating effect); sedating medications: zolpidem (non-benzodiazepine hypnotic — one of the most frequently implicated medications, with numerous case reports of complex sleep behaviours including sleepwalking, sleep-driving, and sleep-eating), quetiapine, lithium, sodium valproate, tricyclic antidepressants, and antihistamines; irregular sleep schedules and circadian disruption (jet lag, shift work — disrupting the timing of SWS); obstructive sleep apnoea (OSA — arousal events during SWS trigger NREM parasomnia; treatment of OSA with CPAP can dramatically reduce sleepwalking episodes); and restless legs syndrome (RLS) and periodic limb movement disorder (PLMD — arousals from limb movements during SWS destabilise the transition between sleep stages).

The clinical presentation of sleepwalking spans a spectrum of complexity from simple to highly elaborate behaviours, all occurring without conscious awareness during Stage N3 sleep. Common episode manifestations: the episode typically begins with the person sitting up in bed with eyes open but with a characteristic blank, glassy, or unseeing expression — the eyes are open but do not track purposefully; the person then may rise from bed and walk around the room, house, or elsewhere; behaviours performed include: routine domestic activities (going to the kitchen, attempting to make food or drinks, using the toilet, or attempting to dress); opening and navigating doors and windows (including leaving the house through an unlocked door — a serious safety hazard); speaking (somniloquy — often incoherent, monosyllabic, or inappropriate responses to questions), and occasionally other person-directed behaviours. In some cases, behaviours can be more complex: operating household appliances, attempting to cook, or using a computer or phone. The sleepwalker appears confused and unresponsive if approached — they do not recognise familiar people, do not follow complex instructions, and do not engage in purposeful conversation. If the person is awakened during an episode (by calling their name repeatedly or shaking them), they typically wake with marked confusion and disorientation lasting several minutes, and subsequently have complete amnesia for all events during the episode (the defining feature — they cannot recall anything that happened during the sleepwalking period). Episodes typically last 1-30 minutes; most episodes are relatively brief (5-15 minutes). Violent or aggressive behaviours during sleepwalking (rare — less than 3% of episodes): the person, if physically restrained or accidentally touched, may reflexively push, strike, or flee from the perceived threat without awareness or intent; this distinction between automatic, stimulus-driven violence (parasomnia) and deliberate violence is clinically and medicolegally important. Atypical features that should raise clinical suspicion of an alternative diagnosis such as nocturnal frontal lobe epilepsy (NFLE): stereotyped or highly repetitive episodes with identical content each time; vocalisation with articulate speech or screaming; very brief episodes (under 2 minutes); occurring late in the sleep period; or multiple episodes per night.

Sleepwalking is primarily a clinical diagnosis based on a characteristic history obtained from the patient and, crucially, from a bed partner or parent who has directly witnessed episodes. The essential diagnostic history includes: timing of episodes (first third of the night — characteristic of NREM parasomnia vs. REM-associated behaviours in REM sleep behaviour disorder, which occur in the second half of the night); behaviour during episodes (complex automatic behaviours without purposeful responses or recall); responsiveness during episodes (unresponsive or confused, not fully awake); recall of episodes (complete amnesia — if the person recalls the episode vividly, the diagnosis is unlikely to be sleepwalking); episode duration (minutes rather than seconds as in epilepsy); and family history of NREM parasomnia. When the clinical history is atypical, concerning, or when the differential diagnosis includes epilepsy, polysomnography with audiovisual monitoring (video-PSG) is the investigation of choice: it captures EEG (showing Stage N3 delta activity with incomplete arousal patterns), EMG (muscle activation during episodes), and video recording of the behaviour pattern; video-PSG also identifies concurrent obstructive sleep apnoea (AHI), periodic limb movements (PLMD), or REM sleep behaviour disorder (RBD) — all of which can precipitate or mimic parasomnia episodes. EEG monitoring: wake and sleep EEG is indicated when nocturnal frontal lobe epilepsy (NFLE) is suspected — NFLE can closely mimic sleepwalking (brief complex motor behaviours during NREM sleep) but shows epileptiform activity (sharp waves or spike-and-wave discharges) on EEG and responds to anticonvulsants (typically carbamazepine or lacosamide) rather than to parasomnia management. MRI brain: performed when seizures are suspected from EEG abnormalities or atypical features — NFLE is frequently caused by focal cortical dysplasia in the frontal lobe that may be visible on high-resolution MRI.

Safety environment modification is the cornerstone: lock doors and windows, use stair gates, remove sharp/breakable objects, alarm systems to alert others. Treat precipitating factors: improve sleep hygiene, treat OSA, review medications. For frequent or injurious episodes: clonazepam 0.25-2 mg at bedtime (reduces SWS arousal) or imipramine; trazodone. Scheduled awakenings in children (wake 15-30 minutes before usual episode time). Regular monitoring of treatment response, early detection of side effects, and ongoing assessment of disease progression are essential components of optimising patient outcomes over the long term. Treatment plans should be proactively reviewed and appropriately adjusted based on clinical response, patient-reported tolerability, changing patient circumstances, and continuously evolving evidence-based clinical guidelines. Meaningful shared decision-making between patients and their healthcare team, incorporating patient values and treatment preferences, consistently improves both treatment adherence and long-term outcomes.

Physical injuries are the most important complication — falls down stairs, walking through glass, or leaving the house can cause serious injury or death. Adults and obese individuals are at higher injury risk than children. Embarrassment and social stigma, sleep disruption for household members, relationship problems, medicolegal issues (sleepwalking-related behavior can rarely lead to violence), and caregiver stress. Long-term specialist follow-up and structured regular review are essential to detect and appropriately manage complications at the earliest possible stage, minimising long-term disability, preserving organ function, and improving the overall prognosis. Patient education about the early warning signs of complications and clear guidance on when to seek urgent medical attention empowers timely help-seeking behaviour and reduces preventable serious adverse outcomes. Psychological impact — including depression, anxiety, and reduced quality of life — should be proactively assessed and addressed as part of comprehensive complication management.

Optimise sleep duration: sleep deprivation is the single most powerful modifiable precipitant of sleepwalking episodes in genetically predisposed individuals; ensuring consistent adequate sleep (7-9 hours for adults, 9-11 hours for school-age children, 9-12 hours for young children) is the most important behavioural preventive measure; increasing sleep opportunity during periods of high stress or illness reduces episode frequency. Maintain consistent sleep and wake schedules every day including weekends: irregular sleep timing disrupts circadian regulation of SWS, creating a more unstable NREM sleep architecture and increasing arousal threshold fluctuations that trigger episodes. Alcohol avoidance: alcohol suppresses REM sleep in the early sleep period and produces REM and SWS rebound later in the night — paradoxically destabilising NREM sleep and triggering episodes in sleepwalkers; even 1-2 drinks within 3 hours of bedtime can trigger an episode in susceptible individuals; total alcohol avoidance in the evening is strongly recommended. Medication review: several medications are known triggers for sleepwalking episodes and should be avoided in known sleepwalkers where clinically possible — in particular, zolpidem (Ambien — the most frequently reported drug-associated sleepwalking trigger, listed on the prescribing label), quetiapine (at low doses used as a sleep aid), lithium, sodium valproate, and antihistamines; review all sleep-promoting medications with the prescriber. Stress management: psychological stress precipitates episodes through increased arousal instability — CBT, mindfulness, and sleep hygiene optimisation during high-stress periods reduce episode frequency. Home safety modifications are non-negotiable for all sleepwalkers: lock exterior doors and windows (install key-operated locks or secondary door alarms); stair gates to prevent falls on stairs; remove potential trip hazards and sharp or breakable objects near the sleeping area; an alarm or door sensor that alerts household members when movement begins allows gentle redirection. Treat OSA: when OSA is identified as a precipitating factor, CPAP treatment eliminates the SWS arousal events triggering episodes and often dramatically reduces or eliminates sleepwalking. Scheduled awakenings: in children with predictable episode timing, gently waking the child 15-30 minutes before the typical episode time interrupts the SWS cycle and prevents episodes — effective in approximately 80% of children when consistently applied.

See your GP for: sleepwalking occurring more than once per week; episodes associated with injury risk (leaving the house, falling down stairs, handling potentially dangerous objects); new onset of sleepwalking in an adult (adult-onset sleepwalking is less common than in childhood and warrants investigation for precipitating causes such as obstructive sleep apnoea, sedating medications, or stress); sleepwalking associated with confusion, agitation, or aggressive behaviour on arousal; or significant distress to the patient or their household members. Request GP referral to a sleep medicine specialist for: persistent sleepwalking despite addressing precipitating factors; episodes that are difficult to distinguish clinically from nocturnal frontal lobe epilepsy (which can closely mimic sleepwalking but requires anticonvulsant treatment rather than simple safety measures); or episodes involving complex, dangerous, or sexual behaviours that may have medicolegal implications. For parents of children who sleepwalk: reassurance is usually sufficient as childhood sleepwalking is typically benign and resolves spontaneously by mid-adolescence. However, if episodes are very frequent, involve dangerous behaviours, or cause significant anxiety in the family, a paediatric sleep assessment is appropriate.